Thujone Exhibits Low Affinity for Cannabinoid Receptors But Fails to Evoke Cannabimimetic Responses

Absinthe, an abused drug in the early 1900s, has been speculated to activate the receptors responsible for marijuana intoxication (the CB1 cannabinoid receptor) (Nature 253:365-356; 1975). To test this hypothesis, we investigated oil of wormwood (Artemisia absinthium) the active plant product found in absinthe, and thujone, the active compound found in oil of wormwood. Radioligand receptor binding assays employing membrane preparations from rat brains containing CB1 cannabinoid receptors, and human tonsils containing CB2 receptors, demonstrated that thujone displaced [3H]CP55940, a cannabinoid agonist, only at concentrations above 10 microM. HPLC analysis of oil of wormwood revealed that only the fractions having mobility close to thujone displaced [3H]CP55940 from the CB1 cannabinoid receptor. [35S]GTPgammaS binding assays revealed that thujone failed to stimulate G-proteins even at 0.1 mM. Thujone failed to inhibit forskolin-stimulated adenylate cyclase activity in N18TG2 membranes at 1 mM. Rats administered thujone exhibited different behavioral characteristics compared with rats administered a potent cannabinoid agonist, levonantradol. Therefore, the hypothesis that activation of cannabinoid receptors is responsible for the intoxicating effects of thujone is not supported by the present data.

[1]  A. Howlett,et al.  Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists. , 1998, Cellular signalling.

[2]  W. Arnold.  Vincent van Gogh:: Chemicals, Crises and Creativity , 1992 .

[3]  M. Montagne,et al.  Absinthe: behind the emerald mask. , 1982, The International journal of the addictions.

[4]  A. Howlett,et al.  Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. , 1988, Molecular pharmacology.

[5]  Susan Budavari,et al.  The Merck index , 1998 .

[6]  J. Lowe,et al.  In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. , 1996, The Journal of pharmacology and experimental therapeutics.

[7]  F. Barth.  Cannabinoid receptor agonists and antagonists , 1998 .

[8]  Brigitte L. Kieffer,et al.  Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene , 1996, Nature.

[9]  E. Duzic,et al.  Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state. , 1994, Molecular pharmacology.

[10]  P. Soubrié,et al.  SR141716A, a potent and selective antagonist of the brain cannabinoid receptor , 1994, FEBS letters.

[11]  M. Herkenham,et al.  The cannabinoid receptor: biochemical, anatomical and behavioral characterization , 1990, Trends in Neurosciences.

[12]  S. Galiègue,et al.  Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. , 1995, European journal of biochemistry.

[13]  H. Bonkovsky,et al.  Porphyrogenic properties of the terpenes camphor, pinene, and thujone (with a note on historic implications for absinthe and the illness of Vincent van Gogh). , 1992, Biochemical pharmacology.

[14]  J. Castillo,et al.  Marijuana, absinthe and the central nervous system , 1975, Nature.

[15]  A. Howlett,et al.  Determination and characterization of a cannabinoid receptor in rat brain. , 1988, Molecular pharmacology.

[16]  K. Rice,et al.  (-)-3-Isothujone, a small nonnitrogenous molecule with antinociceptive activity in mice. , 1976, Journal of medicinal chemistry.

[17]  R. Pertwee.  The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice , 1972, British journal of pharmacology.

[18]  S. Childers,et al.  Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes. , 1996, Life sciences.

[19]  P. Kimmel,et al.  Poison on line--acute renal failure caused by oil of wormwood purchased through the Internet. , 1997, The New England journal of medicine.

[20]  A. Howlett.  Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes. , 1985, Molecular pharmacology.

[21]  Steven B Karch,et al.  The pathology of drug abuse , 1993 .

[22]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[23]  A. Howlett,et al.  Pharmacology of cannabinoid receptors. , 1995, Annual review of pharmacology and toxicology.

[24]  J. Traynor,et al.  Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. , 1995, Molecular pharmacology.

[25]  W. Arnold.  Vincent van Gogh and the thujone connection. , 1988, JAMA.